Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization.
Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors at 8 institutions in 1 country.
Alberto L'AbbateInstitute of Biomembranes, Bioenergetics, and Molecular Biotechnologies, National Research Council (IBIOM-CNR), 70125 Bari, Italy.ORCID 0000-0002-5995-2001
Vittoria MorettiGenomic Medicine Research Center, Department of Medicine and Surgery, University of Insubria, Via JH Dunant 5 Varese, 21100 Varese, Italy.ORCID 0000-0003-1150-5568
Ester PungolinoDivision of Hematology, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milano, Italy.
Giovanni MicheloniGenomic Medicine Research Center, Department of Medicine and Surgery, University of Insubria, Via JH Dunant 5 Varese, 21100 Varese, Italy.ORCID 0000-0002-7666-5311
Roberto ValliGenomic Medicine Research Center, Department of Medicine and Surgery, University of Insubria, Via JH Dunant 5 Varese, 21100 Varese, Italy.ORCID 0000-0002-3209-8917
Annalisa FrattiniGenetics and Biomedical Research Institute, National Research Council (IRGB-CNR), 20090 Milano, Italy.ORCID 0000-0002-1166-3091
Matteo BarcellaDepartment of Health Science, University degli Studi of Milan, Via Rudini 8, 20142 Milan, Italy.
Francesco AcquatiDepartment of Biotechnology and Life Science, University of Insubria, Via JH Dunant 3, 21100 Varese, Italy.ORCID 0000-0002-9537-400X
Rolland A ReinboldInstitute of Biomedical Technologies, National Research Council of Italy, 20054 Segrate, Milano, Italy.
Lucy CostantinoDepartment of Molecular Genetics, Centro Diagnostico Italiano, 20147 Milano, Italy.
Fulvio FerraraDepartment of Molecular Genetics, Centro Diagnostico Italiano, 20147 Milano, Italy.ORCID 0000-0002-5425-4335
Alessandra TrojaniDivision of Hematology, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milano, Italy.ORCID 0000-0002-7659-2968
Mario VenturaDepartment of Biology, University of Bari 'Aldo Moro', Via Edoardo Orabona 4, 70124 Bari, Italy.ORCID 0000-0001-7762-8777
Giovanni PortaGenomic Medicine Research Center, Department of Medicine and Surgery, University of Insubria, Via JH Dunant 5 Varese, 21100 Varese, Italy.
Roberto CairoliDivision of Hematology, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milano, Italy.ORCID 0000-0001-6372-2623
University of Insubria · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITCentro Diagnostico Italiano · ITInstitute of Biomedical Technologies · ITInstitute of Biomembranes, Bioenergetics and Molecular Biotechnologies · ITNational Research Council · ITUniversity of Bari Aldo Moro · ITUniversity of Milan · IT
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Chronic myeloid leukemia (CML) is a rare myeloproliferative disorder caused by the reciprocal translocation t(9;22)(q34;q11) in hematopoietic stem cells (HSCs). This chromosomal translocation results in the formation of an extra-short chromosome 22, called a Philadelphia chromosome (Ph), containing the
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Occurrence of L1M Elements in Chromosomal Rearrangements Associated to Chronic Myeloid Leukemia (CML): Insights from Patient-Specific Breakpoints Characterization. · full record | OpenQuestion